Snowball Research
Research hub for stocks under $5B
⌘K
Subscribe Sign in
activistcompany

TruBridge, Inc (TBRG) announces two directors to join its board as a part of Cooperation Agreements with Pinetree Capital and Ocho Investments

Key Summary: On November 5, 2024, Pinetree Capital Ltd (14.99%) discussed corporate governance improvements with the Board and management, proposing enhanced Board composition for shareholder representation, better alignment of executive compensation, and improved capital allocation. On Feb 12, 2025, the company announced two directors to join its Board as a part of Cooperation Agreements with Pinetree Capital and Ocho Investments.

Market Cap: $398 million | TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

  • On November 5, 2024, Pinetree Capital Ltd (14.99%) engaged in discussions with the Board and management, proposing improvements to corporate governance practices, enhancing Board composition to include shareholder representation, aligning executive compensation appropriately, and improving capital allocation. Source
  • On December 18, 2024, Pinetree Capital Ltd stated that it  has collaborated with the Board on a director assessment process, and had proposed sending a term sheet detailing potential cooperative terms, including recommendations for enhancing corporate governance and Board composition. Source
  • On February 11, 2025, the company announced cooperation agreements with Pinetree Capital Ltd. and Ocho Investments LLC. Through these agreements, TruBridge expanded its board of directors by appointing Jerry Canada and Dris Upitis as independent directors. The agreements include initiatives like declassifying the board and terminating the stockholder rights plan, indicating a strategic move to enhance operational effectiveness and growth.

Member discussion

More like this

Value Base Ltd Opposes Poison Pill, Citing Shareholder Harm at Perion Network Ltd (PERI)

Key Summary: On April 21, 2025, Value Base Ltd (5.85%) opposed the Board's adoption of a Poison

Engine Capital Nominates Directors to Push for Change at Lyft (LYFT)

Key Summary: On April 16, 2025, Engine Capital, owning ~1%, nominated Alan L. Bazaar and Daniel B. Silvers for election

Woodbridge Nominates Two Directors to Replace Retiring Thomson Reuters (TRI) Board Member

Key Summary: On April 16, 2025, Woodbridge nominated Michael Friisdahl and Paul Sagan to replace retiring director W. Edmund Clark

BML Capital Calls for Liquidation and Cash Return at Elevation Oncology (ELEV)

Key Summary: On April 16, 2025, BML Capital Management sent a letter to the Board expressing its belief that an

Soleus Capital Urges ESSA Pharma (EPIX) to Liquidate and Return Cash to Shareholders

Key Summary: On April 15, 2025, Soleus Capital (5.1%) urged ESSA Pharma to wind down operations and return cash

Ocho Publishes Presentation to the Board of Digimarc Corp (DMRC)

Key Summary: On April 14, 2025, Ocho Investments (5.2%) urged Digimarc’s Board to replace the CEO, citing poor